Ted Myles

(Mr. Edward Myles CPA)

Currently holds a position at AMAG Pharmaceuticals Inc

Positions

Position Company Period
Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer AMAG Pharmaceuticals Inc Jan. 9, 2020 -
Independent Director Scholar Rock Holding Corp Nov. 19, 2018 - May 29, 2020
Chief Financial Officer, Executive Vice President, Treasurer AMAG Pharmaceuticals Inc Dec. 31, 2017 - Jan. 9, 2020
Chief Financial Officer, Senior Vice President - Finance, Treasurer AMAG Pharmaceuticals Inc April 11, 2016 - Dec. 31, 2017
Chief Financial Officer, Chief Operating Officer Ocata Therapeutics Inc July 21, 2014 - Feb. 10, 2016
Interim President, Chief Financial Officer, Executive Vice President - Corporate Development Ocata Therapeutics Inc Jan. 22, 2014 - July 21, 2014
Chief Financial Officer, Executive Vice President - Corporate Development Ocata Therapeutics Inc June 12, 2013 - Jan. 22, 2014
Ted Myles's trades of Scholar Rock Holding Corp's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-12 2025-03-10
PS Planned sale
29,395 -20.9%
34.87
USD 1,025,004 		29,395 -20.9% 34.87 USD 1,025,004
2025-03-12 2025-03-10
PS Planned sale
112,897 -44.5%
35.82
USD 4,043,971 		112,897 -44.5% 35.82 USD 4,043,971
2025-02-20 2025-02-18
S Sale
7,809 -5.3%
36.83
USD 287,598 		7,809 -5.3% 36.83 USD 287,598
2025-01-21 2025-01-16
S Sale
12,539 -7.8%
44.20
USD 554,189 		12,539 -7.8% 44.20 USD 554,189
2024-10-10 2024-10-08
PS Planned sale
37,187 -18.8%
34.90
USD 1,297,659 		37,187 -18.8% 34.90 USD 1,297,659
2024-10-07 2024-10-07
PS Planned sale
31,250 -16.2%
29.05
USD 907,813 		31,250 -16.2% 29.05 USD 907,813
2024-10-07 2024-10-07
PS Planned sale
25,812 -11.8%
27.27
USD 703,893 		25,812 -11.8% 27.27 USD 703,893
2024-10-07 2024-10-07
PS Planned sale
37,206 -14.6%
26.83
USD 998,237 		37,206 -14.6% 26.83 USD 998,237
2024-10-07 2024-10-07
PS Planned sale
111,972 -30.5%
25.61
USD 2,867,603 		111,972 -30.5% 25.61 USD 2,867,603
2024-06-18 2024-06-17
S Sale
9,458 -4.5%
8.98
USD 84,978 		9,458 -4.5% 8.98 USD 84,978
2024-02-21 2024-02-16
S Sale
4,744 -2.2%
15.74
USD 74,686 		4,744 -2.2% 15.74 USD 74,686
2024-01-18 2024-01-16
S Sale
6,634 -3.9%
15.93
USD 105,670 		6,634 -3.9% 15.93 USD 105,670
2023-12-29 2023-12-29
PS Planned sale
300 -0.2%
19.51
USD 5,853 		300 -0.2% 19.51 USD 5,853
2023-12-29 2023-12-29
PS Planned sale
12,159 -6.7%
18.82
USD 228,780 		12,159 -6.7% 18.82 USD 228,780
2023-12-08 2023-12-07
PS Planned sale
24,914 -12.9%
17.53
USD 436,820 		24,914 -12.9% 17.53 USD 436,820
2023-11-03 2023-11-02
PS Planned sale
35,007 -17.2%
12.51
USD 438,039 		35,007 -17.2% 12.51 USD 438,039
2021-11-15 2021-11-15
PS Planned sale
4,879 -16.8%
35.05
USD 171,006 		4,879 -16.8% 35.05 USD 171,006
2021-11-15 2021-11-12
PS Planned sale
49,848 -67.4%
35.12
USD 1,750,437 		49,848 -67.4% 35.12 USD 1,750,437
2021-11-15 2021-11-11
PS Planned sale
23,574 -49.4%
35.20
USD 829,857 		23,574 -49.4% 35.20 USD 829,857
// ... existing code ... // ... rest of the file ...